Shoppers choosing to buy less has spooked large groups but costs unlikely to drop even as inflation moderates
GSK
Maker of Marmite and Magnums latest to signal easing of inflationary pressures
Bank shares edge backwards while Glanbia and Irish Continental rise
Drugmaker’s Xevudy fails to tackle most prevalent variants of coronavirus, say US regulators
Kate Ferry to replace Julie Brown who heads to GSK
Drug giant rang up worldwide sales of more than £29 billion last year. Its refusal to contribute a cent to State’s redress scheme is inexcusable
Questions remain about hospitalisation and side effects but drugmaker stays step ahead of British group GSK which faces similar panel
In the News podcast with Bernice Harrison
Clinical trials carried out between 1934 and 1973 centred on childhood vaccines and infant milk products
O’Gorman urged drug firm to accept corporate responsibility for way tests were carried out on mother-and-baby home children
UK drugmaker counting on several new vaccines, including one against RSV, to power growth in 2023
Chief commercial officer Luke Miels looking at targets, especially in cancer therapies, worth up to $2.5bn
YOU MAY ALSO LIKE...
Rugby World Cup: match analysis, interviews, fixtures and results
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices